Bruce Mackle | LifeSci Advisors, IR |
Dr. Steve Fruchtman | President and CEO |
Dr. Victor Moyo | Consultant Chief Medical Officer |
Mark Guerin | Chief Operating Officer and CFO |
Fred Frullo | Vice President, Regulatory Affairs and Quality Assurance |
Edouard Mullarky | Guggenheim |
Ahu Demir | Ladenburg Thalmann |
Robert LeBoyer | Noble Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter [Technical Difficulty]
Sarah, excuse me, you are coming in and out and I don’t know if other people hear.
You coming in and out.
Thank you.